# OnCo record stephen-baylin (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/stephen-baylin/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "stephen-baylin" ;
  schema:name "Stephen B. Baylin"@en ;
  schema:description "Founder of cancer epigenetics, showing that abnormal DNA methylation silences tumour-suppressor genes and can be reversed by drugs."@en ;
  schema:url <https://onco.cc/people/stephen-baylin/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Stephen_B._Baylin>, <https://orcid.org/0000-0003-3697-3798> ;
  schema:citation <https://www.hopkinsmedicine.org/profiles/details/stephen-baylin>, <https://pubmed.ncbi.nlm.nih.gov/?term=Baylin%20SB%5BAuthor%5D> ;
  schema:jobTitle "Virginia and D.K. Ludwig Professor of Oncology and Medicine" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/aml/> ;
  onco:technologies <https://onco.cc/technologies/epigenetic-drugs/>, <https://onco.cc/technologies/methylation-profiling/> ;
  onco:drugs <https://onco.cc/drugs/azacitidine/> ;
  onco:institutions <https://onco.cc/institutions/johns-hopkins/> ;
  onco:journals <https://onco.cc/journals/nature-reviews-cancer/> ;
  schema:affiliation <https://onco.cc/institutions/johns-hopkins/> .